Our Commitment
We are committed to improving the health of people affected by chronic inflammatory and fibrotic diseases.
Learn MoreWe are committed to improving the health of people affected by chronic inflammatory and fibrotic diseases.
Learn MoreWe are focused on developing and commercializing medicines that treat inflammatory and fibrotic diseases by targeting the endocannabinoid system.
We are at the forefront of developing rationally-designed molecules that target the endocannabinoid system to modulate inflammation and fibrosis.
Learn MoreLead Compounds
Ongoing Late-Stage Clinical Studies
Compounds in Library
People Affected by Target Diseases
We are high achievers, creative, innovative and above all else, passionate about what we do.
View Open PositionsThird-party websites are provided for convenience only. Corbus Pharmaceuticals Holdings, Inc. does not approve of, or endorse any of the content. Corbus Pharmaceuticals Holdings, Inc. does not maintain, control or monitor the content of third-party websites in any way.